Literature DB >> 26831194

Roles of Caveolin-1 in Angiotensin II-Induced Hypertrophy and Inward Remodeling of Cerebral Pial Arterioles.

Shaikamjad Umesalma1, Frederick Keith Houwen1, Gary L Baumbach2, Siu-Lung Chan2.   

Abstract

Angiotensin II (Ang II) is a major determinant of inward remodeling and hypertrophy in pial arterioles that may have an important role in stroke during chronic hypertension. Previously, we found that epidermal growth factor receptor is critical in Ang II-mediated hypertrophy that may involve caveolin-1 (Cav-1). In this study, we examined the effects of Cav-1 and matrix metalloproteinase-9 (MMP9) on Ang II-mediated structural changes in pial arterioles. Cav-1-deficient (Cav-1(-/-)), MMP9-deficient (MMP9(-/-)), and wild-type mice were infused with either Ang II (1000 ng/kg per minute) or saline via osmotic minipumps for 28 days (n=6-8 per group). Systolic arterial pressure was measured by a tail-cuff method. Pressure and diameter of pial arterioles were measured through an open cranial window in anesthetized mice. Cross-sectional area of the wall was determined histologically in pressurized fixed pial arterioles. Expression of Cav-1, MMP9, phosphorylated epidermal growth factor receptor, and Akt was determined by Western blotting and immunohistochemistry. Deficiency of Cav-1 or MMP9 did not affect Ang II-induced hypertension. Ang II increased the expression of Cav-1, phosphorylated epidermal growth factor receptor, and Akt in wild-type mice, which was attenuated in Cav-1(-/-) mice. Ang II-induced hypertrophy, inward remodeling, and increased MMP9 expression in pial arterioles were prevented in Cav-1(-/-) mice. Ang II-mediated increases in MMP9 expression and inward remodeling, but not hypertrophy, were prevented in MMP9(-/-) mice. In conclusion, Cav-1 is essential in Ang II-mediated inward remodeling and hypertrophy in pial arterioles. Cav-1-induced MMP9 is exclusively involved in inward remodeling, not hypertrophy. Further studies are needed to determine the role of Akt in Ang II-mediated hypertrophy.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  angiotensin II; caveolin-1; hypertrophy; matrix metalloproteinase-9; mice

Mesh:

Substances:

Year:  2016        PMID: 26831194      PMCID: PMC4752427          DOI: 10.1161/HYPERTENSIONAHA.115.06565

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  31 in total

Review 1.  Caveolins: structure and function in signal transduction.

Authors:  Wanda M Krajewska; Izabela Masłowska
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

Review 2.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 3.  Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle.

Authors:  Masuko Ushio-Fukai; R Wayne Alexander
Journal:  Hypertension       Date:  2006-10-02       Impact factor: 10.190

4.  Remodeling of cerebral arterioles in chronic hypertension.

Authors:  G L Baumbach; D D Heistad
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

5.  Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells.

Authors:  M Ushio-Fukai; R W Alexander; M Akers; Q Yin; Y Fujio; K Walsh; K K Griendling
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

6.  Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo.

Authors:  Daniel G Sedding; Jennifer Hermsen; Ulrike Seay; Oliver Eickelberg; Wolfgang Kummer; Carsten Schwencke; Ruth H Strasser; Harald Tillmanns; Ruediger C Braun-Dullaeus
Journal:  Circ Res       Date:  2005-02-24       Impact factor: 17.367

7.  Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide.

Authors:  Sean Garrean; Xiao-Pei Gao; Victor Brovkovych; Jun Shimizu; You-Yang Zhao; Stephen M Vogel; Asrar B Malik
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

8.  Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.

Authors:  S Eguchi; H Iwasaki; H Ueno; G D Frank; E D Motley; K Eguchi; F Marumo; Y Hirata; T Inagami
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  Caveolin-1 abolishment attenuates the myogenic response in murine cerebral arteries.

Authors:  Adebowale Adebiyi; Guiling Zhao; Sergey Y Cheranov; Abu Ahmed; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-10       Impact factor: 4.733

10.  Deficiency of Nox2 prevents angiotensin II-induced inward remodeling in cerebral arterioles.

Authors:  Siu-Lung Chan; Gary L Baumbach
Journal:  Front Physiol       Date:  2013-06-26       Impact factor: 4.566

View more
  14 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

2.  Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.

Authors:  Steven J Forrester; Katherine J Elliott; Tatsuo Kawai; Takashi Obama; Michael J Boyer; Kyle J Preston; Zhen Yan; Satoru Eguchi; Victor Rizzo
Journal:  Hypertension       Date:  2016-11-28       Impact factor: 10.190

3.  Increased Notch3 Activity Mediates Pathological Changes in Structure of Cerebral Arteries.

Authors:  Celine Baron-Menguy; Valérie Domenga-Denier; Lamia Ghezali; Frank M Faraci; Anne Joutel
Journal:  Hypertension       Date:  2016-11-07       Impact factor: 10.190

Review 4.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

5.  Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.

Authors:  Madhu V Singh; Michael Z Cicha; Sarah Nunez; David K Meyerholz; Mark W Chapleau; François M Abboud
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-22       Impact factor: 4.733

6.  Endothelial Mineralocorticoid Receptor Mediates Parenchymal Arteriole and Posterior Cerebral Artery Remodeling During Angiotensin II-Induced Hypertension.

Authors:  Janice M Diaz-Otero; Courtney Fisher; Kelsey Downs; M Elizabeth Moss; Iris Z Jaffe; William F Jackson; Anne M Dorrance
Journal:  Hypertension       Date:  2017-10-03       Impact factor: 10.190

7.  New Insights Into Mechanisms Associated With Angiotensin II-Induced Vascular Hypertrophy and Remodeling.

Authors:  Sean P Didion
Journal:  Hypertension       Date:  2016-02-01       Impact factor: 10.190

Review 8.  Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?

Authors:  T Michael De Silva; Alyson A Miller
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

Review 9.  Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.

Authors:  Paola Caruso; Riccardo Signori; Rita Moretti
Journal:  Vasc Health Risk Manag       Date:  2019-08-07

Review 10.  Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.